A patient is due for cervical cancer screening. You catch it during her visit, you talk her through why it matters, and you send a referral to OB/GYN. Clinically, that is the right call. For the measure, nothing happened.

A referral to OB/GYN does not meet the measurement [1]. Neither does a biopsy — it is a diagnostic test, and it does not meet HEDIS standards [1]. Those two lines sit in our own CCS quality guide, and together they describe a quiet way to lose credit for care that genuinely happened.

What Actually Closes a CCS Gap

CCS asks a narrow question: was a screening specimen collected, and did a result come back? There are three ways to satisfy it [2]:

• Cervical cytology within the last three years, for women 21 to 64
• High-risk HPV (hrHPV) testing within the last five years, for women 30 to 64
• Cytology and hrHPV co-testing within the last five years, for women 30 to 64

Notice the shape. Every path requires the collection and microscopic analysis of cervical cells [1]. A plan to screen does not count. An order does not count. A colposcopy or biopsy that follows an abnormal result does not count either, because the measure is asking about screening, not about diagnosis [1].

The exclusions are just as literal. Hysterectomy is the one that catches the most practices: documentation of a hysterectomy alone does not exclude the patient, because it does not establish that the cervix was removed. The chart has to say “complete,” “total,” or “radical” — or pair the hysterectomy with documentation that the patient no longer needs Pap testing [2].

Strong Referral Relationships Can Hide Weak Rates

Here is the uncomfortable part. The better your OB/GYN relationships, the more of your panel gets screened outside your walls. That is good medicine. It is also invisible to your rate.

The Pap happens. The result lands in a chart that is not yours. Your gap stays open — not because the patient went unscreened, but because HEDIS scores the record, not the care. A practice can be doing right by every woman on its panel and still post a cervical cancer screening HEDIS compliance rate that says otherwise.

Nothing about that is a clinical failure. It is a records failure, and it is fixable inside the visit you are already having.

Close the Loop in the Room

Ask, then log it properly. Patient-reported screening counts — but only if a provider records it in the chart with both a date and a result [1]. “I had a Pap last year” is not enough on its own. “Pap 3/2025, negative,” entered in the health maintenance section, is [1]. Generic documentation of an “HPV test” counts as evidence of an hrHPV test [1].

Chase the report, not the referral. A lab result noting “no endocervical cells” is acceptable as long as a valid result was reported; a result flagged as an inadequate sample or as containing no cervical cells is not [1]. The artifact you need is the actual report, which means the follow-up your staff should be making is to the lab or the specialist’s office, not to the patient.

Record what happened in CareEmpower®. The Manage Visit drawer carries statuses beyond the default Marked for Closure — Ordered and Previously Completed among them [3]. Gaps flagged Awaiting Chart close once the encounter note or outside report is uploaded [3]. That upload is how a screening performed somewhere else becomes a closed gap on your panel.

Screen in your own exam room when you can. The surest loop to close is the one that never opens. A specimen collected in your office produces a result that lands in your chart by default.

CCS Should be a Part of Every Well-Woman Visit

One more reframe, and it is the one that saves the most staff time: cervical screening probably should not get its own campaign.

On the 10-action Annual Comprehensive Visit checklist, cervical screening does not even get its own line. Cervical, breast, and colorectal are sub-items a, b and c of a single action — number six, Refer for Needed Preventive Screenings [4]. One action, three cancers, one encounter. A patient due for a Pap is very often due for a mammogram, and if she is 45 or older, for colorectal screening as well [5].

Run three single-measure pushes and you reach for the same patient three times and ask your team to work three separate lists. Run the ACV properly and you reach her once. CCS is a Prevention and Screenings measure in every ECIP market [6], so the visit that closes the gap is the same visit that earns activity-based payment for the practice.

Worth noting where this measure comes from. The same month we are asking you to close cervical screening gaps in adults, we are asking you to complete HPV series in adolescents — one dose of meningococcal, one Tdap, and the full HPV series by the 13th birthday [5]. That is not a scheduling coincidence. It is the same disease, 20 years apart, and the vaccine given at 11 or 12 is the upstream half of the Pap you are chasing at 30 [7].

The Takeaway

Screening has cut cervical cancer mortality by more than 50% over the last 30 years [2]. That progress is built on specimens collected and results recorded — not on intent, and not on referrals.

Engagement moves this too. In Arizona, members who had gone 18 months or more without seeing their attributed provider and were then re-engaged by our Care Specialists and Community Health Workers showed 46% higher CCS compliance than members who stayed disengaged [8]. Finding the patient matters. So does making sure her visit ends up in a record your rate can see.

The referral was the right clinical call. It just was not the last one. Ask the question, get the report, and write down the date and the result. That is the whole loop.

References

[1] Equality Health. “Cervical Cancer Screening (CCS) — Quality Measures Guide.” February 2025, p. 2 (Acceptable Documentation).

[2] Equality Health. “Cervical Cancer Screening (CCS) — Quality Measures Guide.” February 2025, p. 1 (Measure Description; Measure Exclusions).

[3] Equality Health. “CareEmpower User Guide.” February 2026 (Manage Visit activity statuses; Awaiting Chart closure path).

[4] Equality Health. “Annual Comprehensive Visits for Adults 18+ (ACV) — Pathways to Better.” June 2025, p. 2 (10-action checklist, action 6: Refer for Needed Preventive Screenings — a. Cervical, b. Breast, c. Colorectal).

[5] NCQA. “HEDIS Measure Crosswalk, MY 2025” (COL-E denominator 45–75; IMA-E Combo 2 by the 13th birthday).

[6] Equality Health. “ECIP Reference Guide 2026” (CCS under Prevention & Screenings, market coverage ALL).

[7] Equality Health. “HPV Vaccines — Quality Guide.” November 2024.

[8] Equality Health Arizona network performance data, 2026 — re-engaged “Lost” members (no attributed-PCP visit in 18+ months) vs. unengaged: CCS +46%.